In two court decisions in less than three months, Johnson & Johnson has been ordered to pay out $127 million. And it faces 1,200 similar lawsuits.
In a recent earnings call, a top official at pharmaceutical giant Johnson & Johnson dismissed questions about drug price reform and described the company as “responsible” in its pricing.
Filings from a lawsuit, scheduled to go to trial Monday in Atlantic City, N.J., describe a previously unreported lobbying campaign by McNeil Consumer Healthcare to protect its iconic painkiller.
Tylenol maker Johnson & Johnson agreed Tuesday to pay a $25 million settlement after pleading guilty to selling medicine contaminated with metal.